79°

Topics

Medicis Pharmaceutical Corporation
Allergan thrives with Botox but is unloading Lap-Band
Allergan thrives with Botox but is unloading Lap-Band

The company: Allergan Inc. Headquarters: Irvine Ticker: AGN Employees: 10,800 Leadership: David E.I. Pyott, chief executive since 1998 Revenue: $5.8 billion in 2012 Net income: $1.1 billion in 2012 Stock price: $108.60 at Friday's close 52-week range: $81.28 to $109.31 P/E ratio: 22.8 based on 2013 estimated earnings Annual dividend: 5 cents, a current yield of about 0.2% The business This is the company that makes Botox. The wrinkle-erasing drug is Allergan's top-selling product — with sales expected to reach $2 billion in 2013. But there's more to Allergan than wrinkle medicine. The self-described "multi-specialty healthcare company" also sells breast implants,...

Loading